Table 3.
Cumulative complications
| Cohort (n=147) |
JIA+ANA (n=58) | JIA−ANA (n=24_ |
ERA (n=9) |
Idiopathic uveitis (n=36) | Sarcoidosis (n=9) |
Other uveitis (n=11) |
|
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Patient with a complication | 101 (69) | 43 (72) | 17 (70) | 2 (22) | 24 (67) | 9 | 6 (54) |
| OHT | 57 (39) | 29 (50) | 10 (42) | 2 (22) | 8 (22) | 4 (44) | 4 (36) |
| OHT surgery | 13 (23) | 7 (24) | 4 (40) | – | 2 (25) | – | – |
| Cataract | 32 (22) | 17 (29) | 10 (42) | – | 2 (5) | 1 (11) | 2 (18) |
| Cataract surgery | 13 (38) | 4 (23) | 4 (40) | – | 2 (100) | 1 (100) | 2 (100) |
| Band keratopathy | 19 (13) | 10 (17) | 4 (17) | – | 5 (13) | – | – |
| Macular oedema | 19 (13) | 7 (12) | 3 (12) | – | 4 (11) | 3 (33) | 2 (18) |
| Optic disk oedema | 37 (26) | 11 (19) | 5 (21) | – | 6 (17) | 9 | 6 (54) |
ANA, antinuclear antibody; ERA, enthesitis-related arthritis; JIA, juvenile idiopathic arthritis; OHT, ocular hypertension.